Biosyngen is a cell therapy company focused on addressing unmet medical needs through innovative technology. Our pipeline includes Phase I/II clinical trials for nasopharyngeal cancer and lymphoproliferative disease, with plans for additional indications. We leverage a dual HQ structure in Singapore...See more
Headquarter Singapore |
Countries of operation Singapore |
Year founded 2016 (8 years) |
Funding status Private |
Company type SME |
Founder
Chief Scientist
M&E Facilities Executive
Share capital injection/new funding: approx. SGD 660,550
The company has corporate shareholder(s) or more than 20 individual shareholders
The company is owned by individual shareholder(s), it has no corporate shareholder.
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
Fiscal/Budgeting Period: | October - December |
Auditor: | CS PRACTICE PAC |
Corporate-only access Contact us for a free demo now! | |
Sign up to view for free |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 1 Jul 2016 | Singapore | SGD 32,318,958 | 72106: RESEARCH AND EXPERIMENTAL DEVELOPMENT ON MEDICAL SCIENCE |
| 1 Feb 2018 | Singapore | SGD 1,978,035 | 72106: RESEARCH AND EXPERIMENTAL DEVELOPMENT ON MEDICAL SCIENCE |
| 13 Nov 2019 | Singapore | SGD 10,000 | 72106: RESEARCH AND EXPERIMENTAL DEVELOPMENT ON MEDICAL SCIENCE |